Atıf İçin Kopyala
Tuncer S., Tanyildiz B., Basaran M., Buyukbabani N., Dogan O.
CURRENT EYE RESEARCH, cilt.40, sa.8, ss.780-785, 2015 (SCI-Expanded)
Purpose: To evaluate the efficacy of systemic rituximab immunotherapy in the management of primary ocular adnexal lymphomas (OAL).